Bromazolam formulations are a relatively recent development in the realm of pharmaceuticals. These discrete increments offer a targeted method for administering bromazolam, a potent CNS depressant. While investigations on bromazolam pellets are still developing, early findings suggest their potential effectiveness in treating a spectrum of conditio